Dimethyl fumarate for the treatment of multiple sclerosis
US7320999B2 · kind B2 · utility
73Cited by
20References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2002 |
| Grant date | Jan 22, 2008 |
| Priority date | — |
| Expiry date | Feb 4, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2095
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets. For this purpose, the dialkyl fumarates may also be used in combination with conventional preparations used in transplantation medicine and immunosuppressive agents, especially cyclosporines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.